The First Russian Experience of Using Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Two Case Reports | Nikishina | Pediatric pharmacology

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Preview

Pediatric pharmacology

Advanced search

Archives

Download this PDF file

For citations:

Nikishina I.P., Matkava V.G., Arsenyeva S.V., Gasymov E.G., Arefieva A.N. The First Russian Experience of Using Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Two Case Reports. Pediatric pharmacology. 2025;22(1):19-30. (In Russ.) https://doi.org/10.15690/pf.v22i1.2851

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Editor-in-Chief

Leyla S. Namazova-Baranova

Popular articles

* not an advertisement

Indexing Databases

* not an advertisement

Article Tools

Abstract

Print this article

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Irina P. Nikishina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

MD, PhD

34A, Kashirskoe shosse, Moscow, 115522

Valeriya G. Matkava
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

MD

Moscow

Svetlana V. Arsenyeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

MD

Moscow

Emil G. Gasymov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

MD

Moscow

Alia N. Arefieva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

MD

Moscow

Notifications